Skip to content

H2020FP7HORIZON

Janssen Pharmaceutica NV

Country
BEBelgium
Defence projects
0
Projects, all programmes
131
As coordinator
6
EU contribution (CORDIS)
EUR 10,443,749
Active
2008 to 2025

Projects

131 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
PATH-TOXArtificial Intelligence to transform Drug and Chemical safety testingH20202018CoordinatorEUR 134,531
EHDENEuropean Health Data and Evidence NetworkH20202018ParticipantEUR 0
DO-ITBig Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055H20202017ParticipantEUR 0
EQIPDEuropean Quality In Preclinical DataH20202017ParticipantEUR 0
PyroPopMechanisms and regulation of inflammasome-associated programmed cell deathH20202017ParticipantEUR 729,100
M-GATEMemory research: Ground-breaking, Applied, and Technological ExchangesH20202017ParticipantEUR 250,560
ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064H20202017ParticipantEUR 0
IMPRiNDInhibiting Misfolded protein PRopagation in Neurodegenerative Diseases - Sofia ref.: 116060H20202017ParticipantEUR 0
HARMONYHealthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026H20202017ParticipantEUR 0
TransQSTTranslational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030H20202017ParticipantEUR 0
PICPersonalised In-Silico CardiologyH20202017PartnerEUR 0
H-CCATSolid Catalysts for activation of aromatic C-H bondsH20202017ParticipantEUR 1,019,475
eTRANSAFEEnhacing TRANslational SAFEty Assessment through Integrative Knowledge ManagementH20202017ParticipantEUR 0
RESCEUREspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019H20202017ParticipantEUR 0
RTCureRheuma Tolerance for CureH20202017ParticipantEUR 0
PurinesDXInterdisciplinary training network on the purinergic P2X7 receptor to control neuroinflammation and hyperexcitability in brain diseases.H20202017PartnerEUR 0
ADAPTEDAlzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975H20202016ParticipantEUR 0
PREFERPatient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966H20202016ParticipantEUR 0
AMYPADAmyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952H20202016ParticipantEUR 0
AIMMS STAR-PLUSScientific Top Training in Antimicrobial ResearchH20202016PartnerEUR 0

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.